Featured Research

from universities, journals, and other organizations

UW Medical Center To Implant First-ever Cesium-131 Brachytherapy Seeds To Treat Prostate Cancer

Date:
November 2, 2004
Source:
University Of Washington
Summary:
In the first significant advancement in brachytherapy in more than 15 years, physicians at UW Medical Center have today (Oct. 26) implanted for the first time in the world a new type of radioactive seeds in a prostate cancer patient.

The dime shows the size of the radioactive seeds used in the implant procedure.
Credit: Photo Blayne Vixie / Courtesy of University Of Washington

In the first significant advancement in brachytherapy in more than 15 years, physicians at UW Medical Center have today (Oct. 26) implanted for the first time in the world a new type of radioactive seeds in a prostate cancer patient.

The cesium-131 (Cs-131) brachytherapy implant seed, developed by IsoRay of Richland, Wash., provides another viable option for men with prostate cancer, said Dr. Leroy Korb, assistant professor of radiation oncology at UW Medical Center.

"The Cs-131 seed developed by IsoRay offers a shorter half-life and faster delivery of the total radiation dose than the other types of seeds currently on the market," Korb said. "We believe it will be an effective option for men choosing brachytherapy to treat their prostate cancer."

The Cs-131 seed has a half-life of 9.7 days, compared to 60 days for iodine-125 seeds. It delivers more than 90 percent of its total radiation dose in less than 33 days.

"The new Cs-131 seed has a significantly higher dose rate than iodine, allowing for the delivery of more radiation in a shorter period of time to maximize its effectiveness," Korb said. "The treatment is over in one-sixth the time of iodine seeds and leaves the body 500 days faster."

Korb and Dr. William Ellis, professor of urology, will implant the first Cs-131 seeds in a 74-year-old Brookings, Ore., man in a procedure in UW Medical Center's new Surgery Pavilion. The procedure is completed in 45 to 60 minutes. Needles are used to implant the seeds, which are smaller than a grain of rice. No incision or suturing is required, and the patient usually doesn't need to stay overnight.

The patient is usually back to his normal work and daily activities within two to three days. After about three months, doctors will check to measure the effectiveness of the treatment.

Due to the shorter duration of treatment with Cs-131, side effects such as incontinence, urinary urgency or pain may be lessened, Korb said. Men who had good erectile function prior the implant should not experience any problems following the procedure.

Prostate cancer is one of the leading causes of death among men. About 230,000 men will be diagnosed with prostate cancer this year in the United States, and about 40,000 will die of the disease.

Ellis said that among patients in the UW prostate cancer program, about 50 percent have chosen surgery and the other 50 percent have chosen radiation treatment. Of the group that chose radiation, about 30 percent had external beam radiation and 20 percent had implanted seeds.

"We are very pleased to be the first to offer this new type of treatment at UW Medical Center and to partner with IsoRay, a Washington-based company," Korb said.


Story Source:

The above story is based on materials provided by University Of Washington. Note: Materials may be edited for content and length.


Cite This Page:

University Of Washington. "UW Medical Center To Implant First-ever Cesium-131 Brachytherapy Seeds To Treat Prostate Cancer." ScienceDaily. ScienceDaily, 2 November 2004. <www.sciencedaily.com/releases/2004/10/041029105025.htm>.
University Of Washington. (2004, November 2). UW Medical Center To Implant First-ever Cesium-131 Brachytherapy Seeds To Treat Prostate Cancer. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2004/10/041029105025.htm
University Of Washington. "UW Medical Center To Implant First-ever Cesium-131 Brachytherapy Seeds To Treat Prostate Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/10/041029105025.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins